A bipartisan legislation aimed at stopping the flow of fentanyl and its precursors into the United States was recently introduced in the Senate, with the aim of holding Chinese entities accountable for exporting these drugs.
Sens. Jim Risch (R-Idaho) and Jeanne Shaheen (D-N.H.), chairman and ranking member of the Foreign Relations Committee respectively, introduced the “Break Up Suspicious Transactions of Fentanyl Act” on March 6. The legislation does not link to tariffs but aims to give the U.S. president more authority to impose sanctions on China’s state-owned or state-controlled entities, including financial institutes, for contributing to fentanyl trafficking.
“With the support of the Chinese government, China remains the single greatest source of fentanyl and synthetic opioid precursors to Mexican cartels,” Risch said in a statement. “These opioids then come across our southern border and kill over 100,000 Americans every year. This needs to end and the perpetrators need to be held accountable.”…
Bipartisan Senate Bill Seeks to Curb Flow of Fentanyl Into the US From China
